Investing In
United Kingdom
20 August 2025
Fieldfisher‘s team, renowned for its ’deep understanding of the life science landscape in the UK‘ handles work spanning key stage funding for novel transactional funding for pharmaceutical products, regulatory assistance in areas of new technologies and M&A work in the life sciences space. ’Very experienced operator’ Janita Good heads up the team and is equipped to assist clients with M&A exits and pharma IP partnering deals. Sarah Ellson is frequently called upon to assist with appeals against commercial decisions made by NICE. Vicky Reinhardt, dual qualified in Germany and England, is well placed to assist life sciences clients with the commercial exploitation of products.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The team has domain expertise, market knowledge and understanding, a network in the sector and a track record and experience.'
- 'Janita Good is a very experienced operator in the Life Science sector in the UK and she is very skilful at finding clever solutions to thorny issues and getting projects successfully over the line.'
Key clients
- ALSA Ventures
- Link Biologics
- Novartis
- Inspiration Healthcare plc
- Syneos Health UK
- LetterOne
- Human Tissue Authority
- NHS Resolution
- Phoenix Healthcare/Numark
- General Medical Council
Work highlights
Advised Link Biologics on a simultaneous in-licence from the University of Manchester and out-licence to French pharmaceutical company Laboratoire Thea and its affiliate Thea Open Innovation.
Advised blood cancer charity Myeloma UK on two separate successful appeals against decisions made by the National Institute for Health and Care Excellence (NICE).
Advised Novartis on local regulations and legislation in relation to Patient Support Programmes (PSPs) in over 38 countries.
Practice head
Janita Good
Other key lawyers
Sarah Ellson; Vicky Reinhardt; Joshua Cronin